Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study.
Saved in:
| Title: | Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study. |
|---|---|
| Authors: | Álvarez H; Department of Internal Medicine, Infectious Diseases Unit, Complexo Hospitalario Universitario de Ferrol, Ferrol, SERGAS-A Coruña, Spain.; Department of Biochemistry, Genetics and Immunology, Universidade de Vigo, Vigo, Spain., Mocroft A; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom., Ryom L; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Infectious Diseases, Hvidovre University Hospital, Copenhagen, Denmark., Neesgaard B; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Edwards S; Department of HIV, Mortimer Market Centre, London, United Kingdom., Svedhem V; Department of Medicine, Medical Unit Infectious Diseases, Karolinska University Hospital, Karolinska Institutet, Huddinge, Sweden., Günthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Zangerle R; Austrian HIV Cohort Study, Medizinische Universität Innsbruck, Innsbruck, Austria., Smith C; The Royal Free HIV Cohort Study, Royal Free Hospital, University College London, London, United Kingdom., Castagna A; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy., d'Arminio Monforte A; Italian Cohort Naive Antiretrovirals (ICONA), ASST Santi Paolo e Carlo, Milano, Italy., Wit F; AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort, HIV Monitoring Foundation, Amsterdam, The Netherlands., Stecher M; Division of Infectious Diseases, Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany., Lehman C; Division of Infectious Diseases, Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany., Mussini C; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy., Fontas E; Nice HIV Cohort, Université Côte d´Azur et Centre Hospitalier Universitaire, Nice, France., González E; PISCIS Cohort Study, Centre Estudis Epidemologics de ITS i VIH de Catalunya, Badalona, Spain., Wasmuth JC; Medical Department, University Hospital Bonn, Bonn, Germany., Sönnerborg A; Swedish InfCare HIV Cohort, Karolinska University Hospital, Stockholm, Sweden., De Wit S; CHU Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium., Chkhartishvili N; Georgian National AIDS Health Information System, Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia., Stephan C; Frankfurt HIV Cohort Study, University Hospital Frankfurt, Goethe-University, Infectious Diseases Unit, Frankfurt, Germany., Petoumenos K; The Kirby Institute, University of New South Wales, Sydney, Australia., Jaschinski N; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Vannappagari V; ViiV Healthcare, Research Triangle Park, North Carolina, USA., Gallant J; Gilead Sciences, Foster City, California, USA., Young L; Merck Sharp & Dohme, Luzern, Switzerland., Volny Anne A; European AIDS Treatment Group, Brussels, Belgium., Greenberg L; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom., Martín-Iguacel R; Infectious Diseases Department, Odense University Hospital, Odense, Denmark., Poveda E; Group of Virology and Pathogenesis, Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, Vigo, SERGAS-UVigo, Spain., Llibre JM; Infectious Diseases Division and Fight Infections Foundation, University Hospital Germans Trias i Pujol, Barcelona, Spain. |
| Corporate Authors: | RESPOND (International Cohort Consortium of Infectious Diseases) Study Group |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Aug 22; Vol. 77 (4), pp. 593-605. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6591 |
|---|---|
| DOI: | 10.1093/cid/ciad219 |
